Office What do I take, ibuprofen or paracetamol?
Health Europe warns of possible serious damage from the abuse of ibuprofen with codeine
The European Medicines Agency (
EMA
) has launched a review of
medicines
containing
pseudoephedrine
, used to
treat nasal congestion
caused by a cold, flu or allergy, due to concerns about the
risk of developing diseases
that affect the blood vessels of the brain.
These drugs are being reviewed by the EMA's safety committee (PRAC), following the publication of
new data on a "small number" of people
using pseudoephedrine-containing medicines who have developed
posterior reversible encephalopathy syndrome
(PRES) or
vasoconstriction syndrome .
reversible stroke
(RCVS).
"PRES and RCVS
can involve reduced blood supply (ischemia) to the brain
and can cause serious and life-threatening complications in some cases. Common symptoms associated with PRES and RCVS include headache, nausea and seizures," the EMA explained. it's a statement.
The EMA notification includes a list of medicines under surveillance that contain
pseudoephedrine
, among them there are
31 that are marketed in Spain
.
These are:
bisolfren
Cinfatós Comple
Decongestant Cinfatós
ClaritynePlus
cold cutter C
Decongestant Frenadol
frenaxsin
Gelocatil Influenza With Pseudoephedrine
Grippal With Pseudoephedrine And Dextromethorphan
Ibuprofen/Pseudoephedrine Nutra Essential
Ilvisinus
Inistolin Pediatric Cough And Congestion
Iniston Mucus And Congestion
Iniston Cough And Congestion
lasa with codeine
Narine Repetabs
pharmafren
pharmatusgrip
Pseudoephedrine Farmalider
React
Respidin
Respidin Antiallergic
Respidin Expectorant Junior
rhinobactil
Rino Ebastel
stopcold
Thermalgin Cold
Vincigrip
Vincigrip Forte Cocoa Flavor
Vincigrip Forte Orange Flavor
Virlix Plus
pseudoephedrine
Pseudoephedrine
is taken by mouth
and used
alone or in combination with other medications
to treat nasal congestion resulting from a cold, flu, or allergy.
Restrictions and warnings about this product are already included in its package insert.
Drugs with pseudoephedrine have a
known risk of "cardiovascular and cerebrovascular ischemic events
(side effects involving ischemia in the heart and brain), including cerebrovascular accidents and heart attacks," recalls the European agency.
The PRAC will now assess the general safety profile of pseudoephedrine and the indications for which medicines containing it are approved, and will decide whether the European license for these drugs should be "maintained, modified, suspended or withdrawn" from all European Union (EU).
According to the criteria of The Trust Project
Know more
European Union
Flu
Europe
doping